BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32056145)

  • 21. Overexpressed TP73 induces apoptosis in medulloblastoma.
    Castellino RC; De Bortoli M; Lin LL; Skapura DG; Rajan JA; Adesina AM; Perlaky L; Irwin MS; Kim JY
    BMC Cancer; 2007 Jul; 7():127. PubMed ID: 17626635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological features of medulloblastoma: an overview with an emphasis on molecular biology.
    de Haas TG; Kool M
    Clin Neuropathol; 2007; 26(3):93-110. PubMed ID: 19157001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medulloblastoma: molecular genetics and animal models.
    Raffel C
    Neoplasia; 2004; 6(4):310-22. PubMed ID: 15256053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular characterization of medulloblastomas with extensive nodularity (MBEN).
    Korshunov A; Sahm F; Stichel D; Schrimpf D; Ryzhova M; Zheludkova O; Golanov A; Lichter P; Jones DTW; von Deimling A; Pfister SM; Kool M
    Acta Neuropathol; 2018 Aug; 136(2):303-313. PubMed ID: 29569031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on the integrated histopathological and genetic classification of medulloblastoma - a practical diagnostic guideline.
    Pietsch T; Haberler C
    Clin Neuropathol; 2016; 35(6):344-352. PubMed ID: 27781424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptional profiling of medulloblastoma with extensive nodularity (MBEN) reveals two clinically relevant tumor subsets with VSNL1 as potent prognostic marker.
    Korshunov A; Okonechnikov K; Sahm F; Ryzhova M; Stichel D; Schrimpf D; Ghasemi DR; Pajtler KW; Antonelli M; Donofrio V; Mastronuzzi A; Rossi S; Camassei FD; Buccoliero AM; Haberler C; Slavc I; Dahiya S; Casalini B; Sievers P; Meyer J; Kumirova E; Zheludkova O; Golanov A; Jones DTW; Pfister SM; Kool M; von Deimling A
    Acta Neuropathol; 2020 Mar; 139(3):583-596. PubMed ID: 31781912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study.
    Schwalbe EC; Lindsey JC; Nakjang S; Crosier S; Smith AJ; Hicks D; Rafiee G; Hill RM; Iliasova A; Stone T; Pizer B; Michalski A; Joshi A; Wharton SB; Jacques TS; Bailey S; Williamson D; Clifford SC
    Lancet Oncol; 2017 Jul; 18(7):958-971. PubMed ID: 28545823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Germline microsatellite genotypes differentiate children with medulloblastoma.
    Rivero-Hinojosa S; Kinney N; Garner HR; Rood BR
    Neuro Oncol; 2020 Jan; 22(1):152-162. PubMed ID: 31562520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High levels of PROM1 (CD133) transcript are a potential predictor of poor prognosis in medulloblastoma.
    Raso A; Mascelli S; Biassoni R; Nozza P; Kool M; Pistorio A; Ugolotti E; Milanaccio C; Pignatelli S; Ferraro M; Pavanello M; Ravegnani M; Cama A; Garrè ML; Capra V
    Neuro Oncol; 2011 May; 13(5):500-8. PubMed ID: 21486962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathway analysis supports association of nonsyndromic cryptorchidism with genetic loci linked to cytoskeleton-dependent functions.
    Barthold JS; Wang Y; Kolon TF; Kollin C; Nordenskjöld A; Olivant Fisher A; Figueroa TE; BaniHani AH; Hagerty JA; Gonzaléz R; Noh PH; Chiavacci RM; Harden KR; Abrams DJ; Kim CE; Li J; Hakonarson H; Devoto M
    Hum Reprod; 2015 Oct; 30(10):2439-51. PubMed ID: 26209787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Common genetic variation and risk of gallbladder cancer in India: a case-control genome-wide association study.
    Mhatre S; Wang Z; Nagrani R; Badwe R; Chiplunkar S; Mittal B; Yadav S; Zhang H; Chung CC; Patil P; Chanock S; Dikshit R; Chatterjee N; Rajaraman P
    Lancet Oncol; 2017 Apr; 18(4):535-544. PubMed ID: 28274756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrospective investigation of hereditary syndromes in patients with medulloblastoma in a single institution.
    Wang Y; Wu J; Li W; Li J; Liu R; Yang B; Li C; Jiang T
    Childs Nerv Syst; 2021 Feb; 37(2):411-417. PubMed ID: 32930885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endometrial vezatin and its association with endometriosis risk.
    Holdsworth-Carson SJ; Fung JN; Luong HT; Sapkota Y; Bowdler LM; Wallace L; Teh WT; Powell JE; Girling JE; Healey M; Montgomery GW; Rogers PA
    Hum Reprod; 2016 May; 31(5):999-1013. PubMed ID: 27005890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Profile of common prostate cancer risk variants in an unscreened Romanian population.
    Iordache PD; Mates D; Gunnarsson B; Eggertsson HP; Sulem P; Guðmundsson J; Benónísdóttir S; Csiki IE; Rascu S; Radavoi D; Ursu R; Staicu C; Calota V; Voinoiu A; Jinga M; Rosoga G; Danau R; Sima SC; Badescu D; Suciu N; Radoi V; Manolescu A; Rafnar T; Halldórsson BV; Jinga V; Stefánsson K
    J Cell Mol Med; 2018 Mar; 22(3):1574-1582. PubMed ID: 29266682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medulloblastomas associated with an APC germline pathogenic variant share the good prognosis of CTNNB1-mutated medulloblastomas.
    Surun A; Varlet P; Brugières L; Lacour B; Faure-Conter C; Leblond P; Bertozzi-Salomon AI; Berger C; André N; Sariban E; Raimbault S; Prieur F; Desseigne F; Zattara H; Guimbaud R; Polivka M; Delisle MB; Vasiljevic A; Maurage CA; Figarella-Branger D; Coulet F; Guerrini-Rousseau L; Alapetite C; Dufour C; Colas C; Doz F; Bourdeaut F
    Neuro Oncol; 2020 Jan; 22(1):128-138. PubMed ID: 31504825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03).
    Gajjar A; Robinson GW; Smith KS; Lin T; Merchant TE; Chintagumpala M; Mahajan A; Su J; Bouffet E; Bartels U; Schechter T; Hassall T; Robertson T; Nicholls W; Gururangan S; Schroeder K; Sullivan M; Wheeler G; Hansford JR; Kellie SJ; McCowage G; Cohn R; Fisher MJ; Krasin MJ; Stewart CF; Broniscer A; Buchhalter I; Tatevossian RG; Orr BA; Neale G; Klimo P; Boop F; Srinivasan A; Pfister SM; Gilbertson RJ; Onar-Thomas A; Ellison DW; Northcott PA
    J Clin Oncol; 2021 Mar; 39(7):822-835. PubMed ID: 33405951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non-coding RNA profiling of pediatric Medulloblastoma.
    Kesherwani V; Shukla M; Coulter DW; Sharp JG; Joshi SS; Chaturvedi NK
    BMC Med Genomics; 2020 Jun; 13(1):87. PubMed ID: 32591022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medulloblastoma genomics in the modern molecular era.
    Kumar R; Liu APY; Northcott PA
    Brain Pathol; 2020 May; 30(3):679-690. PubMed ID: 31799776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medulloblastoma, WNT-activated/SHH-activated: clinical impact of molecular analysis and histogenetic evaluation.
    Cambruzzi E
    Childs Nerv Syst; 2018 May; 34(5):809-815. PubMed ID: 29582169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in the molecular classification of pediatric brain tumors: a guide to the galaxy.
    Cacciotti C; Fleming A; Ramaswamy V
    J Pathol; 2020 Jul; 251(3):249-261. PubMed ID: 32391583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.